Literature DB >> 8532075

Cultured chick sympathetic neurons: prostanoid EP1 receptor-mediated facilitation of noradrenaline release.

C Allgaier1, W Meder.   

Abstract

Prostanoid EP receptor-mediated modulation of noradrenaline release from cultured chick sympathetic neurons was investigated. Transmitter release from dissociated cell cultures of embryonic paravertebral ganglia, loaded with [3H]-noradrenaline, was elicited either by electrical field stimulation (36 pulses/3 Hz) or by elevating the extracellular concentration of K+ (to 30 mM; for 2 min). Prostaglandin E2 (PGE2; 0.01-3 microM) enhanced electrically evoked [3H]-noradrenaline release in a concentration-dependent manner with a maximal increase by about 50% at 1 microM. Also iloprost (0.1-3 microM) increased transmitter release concentration- dependently, whereas misoprostol (0.1-3 microM) had no effect. Indometacin (10 microM) influenced neither evoked release per se nor the enhancement caused by PGE2- AH6809 (3 microM), a selective EP1 receptor antagonist, blocked the enhancement caused by both PGE2 and iloprost K(+)-evoked noradrenaline release, which was virtually insensitive to tetrodotoxin (0.3 microM), was increased by PGE2 to an extent comparable to that observed after electrical stimulation. In summary, the present data indicate that PGE2 facilitates noradrenaline release from cultured chick sympathetic neurons by a receptor which shows the pharmacological profile of the EP1 subtype and is probably located at the processes of the neuron.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532075     DOI: 10.1007/bf00172784

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

Review 1.  Basic mechanisms of prostaglandin action on autonomic neurotransmission.

Authors:  P Hedqvist
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

Review 2.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer.

Authors:  P C Waldmeier; P A Baumann; K Hauser; L Maitre; A Storni
Journal:  Biochem Pharmacol       Date:  1982-06-15       Impact factor: 5.858

4.  Antagonism of prostaglandin E2 by 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f) (1,4) oxazepine-10-carbonyl) hydrazine (SC-19220).

Authors:  J H Sanner
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-07

5.  Neuroeffector actions of thromboxane B2 in dog isolated mesenteric arteries.

Authors:  T Okamura; M Nakajima; N Toda
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

6.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

7.  Prejunctional and postjunctional actions of prostaglandins F2 alpha and I2 and carbocyclic thromboxane A2 in isolated dog mesenteric arteries.

Authors:  M Nakajima; N Toda
Journal:  Eur J Pharmacol       Date:  1986-01-29       Impact factor: 4.432

8.  Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

Authors:  G J Molderings; E Colling; J Likungu; J Jakschik; M Göthert
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

9.  Comparison of transmitter release properties of embryonic sympathetic neurons growing in vivo and in vitro.

Authors:  A R Wakade; T D Wakade
Journal:  Neuroscience       Date:  1988-12       Impact factor: 3.590

Review 10.  Prostaglandins and the release of the adrenergic transmitter.

Authors:  K U Malik; E Sehic
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.